Role of Eosinophils in the Proliferation of Airway Smooth Muscle (ASM) Cells
NCT01082952 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2011-11-18
Summary
Being a key player in Asthma, eosinophils constitute a potential target to interfere with the series of biological events leading to Asthma pathogenesis. In this proposal, the investigators hypothesize that the interaction between eosinophils and airway smooth muscle cells (ASM) cells plays an important role in airway remodeling. Hence the investigators will investigate the role of eosinophils in enhancing ASM cells proliferation resulting in airways remodeling. The investigators will also investigate the mechanism behind this phenomenon. This will then pave the way for medical (drug) interference at one or several sites in order to prevent one of the main potential reasons behind airway remodeling, namely eosinophil-derived ASM proliferation.
Conditions
Sponsors & Collaborators
-
King Saud University
lead OTHER
Principal Investigators
-
Saleh Al-Muhsen, MD · King Saud University
-
Rabih Halwani, PhD · King Saud University
Eligibility
- Min Age
- 14 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854 ·Status: COMPLETED ·Phase: NA
-
Inhaled Corticosteroids on Airway Smooth Muscle in Asthma
NCT00661973 ·Status: WITHDRAWN ·Phase: PHASE4
-
Mechanistic Insights From Bronchoscopy Airway Samples
NCT06105710 ·Status: RECRUITING
-
Endotoxin and Bronchial Inflammation in Asthma
NCT00005550 ·Status: COMPLETED
-
Role of T-Cells in Asthma
NCT00001408 ·Status: COMPLETED
-
Phenotypic and Functional Characterization of Neutrophils and Eosinophils in Severe Asthma Treated With Biotherapy
NCT05972213 ·Status: RECRUITING
-
Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE)
NCT05214599 ·Status: WITHDRAWN ·Phase: PHASE2
-
Non-coding RNAs Analysis of Eosinophil Subtypes in Asthma
NCT04542902 ·Status: UNKNOWN ·Phase: NA
-
Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics
NCT01420003 ·Status: COMPLETED ·Phase: NA
-
Bronchial Allergen Provocation Tests in Asthmatics in Guangzhou
NCT02504528 ·Status: COMPLETED ·Phase: NA
-
Flow Cytometry Analysis of Eosinophils in Severe Asthma Patients.
NCT05001529 ·Status: UNKNOWN ·Phase: PHASE4
-
AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma
NCT01018550 ·Status: COMPLETED ·Phase: PHASE2
-
A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients
NCT00331292 ·Status: TERMINATED
-
Lung Fluid and Peripheral Blood Neutrophil IL-5 Surface Receptor in Children With Asthma
NCT02866487 ·Status: COMPLETED
-
Study of the Inflammation and Airway Changes That Occur After Exposure to Allergen in Asthmatics
NCT02230189 ·Status: COMPLETED ·Phase: PHASE2
-
Airway Temperature
NCT02401074 ·Status: WITHDRAWN ·Phase: PHASE1
-
An Investigation of Tumor Necrosis Factor (TNF)-Alpha in Asthma Using Biopsy Explants and Primary Bronchial Epithelial Cell Cultures
NCT01161303 ·Status: COMPLETED
-
Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis
NCT00762073 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma
NCT00587288 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
How Airway Remodeling and Hyperresponsiveness Contribute to Airflow Obstruction in Asthma
NCT00186693 ·Status: WITHDRAWN
-
Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1)
NCT01006161 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma
NCT00550797 ·Status: COMPLETED ·Phase: PHASE2
-
Factors Involved in Asthma and Airway Inflammation
NCT00001887 ·Status: COMPLETED
-
The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma
NCT00133042 ·Status: COMPLETED ·Phase: PHASE4